Atlas Trials

Taladegib, Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Localized Esophageal or Gastroesophageal Junction Cancer

Clinical trial NCT02530437 · TERMINATED

Trial details

NCT number
NCT02530437
Sponsor
M.D. Anderson Cancer Center
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Gastroesophageal Junction AdenocarcinomaStage IB Esophageal Adenocarcinoma AJCC v7Stage II Esophageal Adenocarcinoma AJCC v7Stage IIA Esophageal Adenocarcinoma AJCC v7Stage IIB Esophageal Adenocarcinoma AJCC v7Stage IIIA Esophageal Adenocarcinoma AJCC v7Stage IIIB Esophageal Adenocarcinoma AJCC v7
Start date
2017-03-07
Primary completion
2022-01-07
Enrollment
7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.